Hi everybody, I'm new in Illumina MiSeq, I have one question, what is the meaning of to do a previous balancing of the run of a multiplexing library by mean of nanoflow cells. In a process in my institution will be used a previous step of balancing using a nanoflow cell, and after this will be done the sequencing process using a full flow cell run. I don't understand why the previews process using the nanoflow cell could balancing the run?
Unconfigured Ad
Collapse
X
-
Tags: None
-
I guess what your institution is doing is using a short MiSeq run to check the evenness of multiplexed pools. So for example if there is a 10 sample pool they would be looking to see of each sample gets about 10% of the total number of reads. The data would also be useful to look at other things like insert sizes and screening for contaminants like rRNA in RNA-Seq libraries. While this may be helpful to troubleshoot a bad library, it's usefulness diminishes as the level of multiplexing goes up since it would be very difficult to re-adjust any one particular sample with precision.
-
-
Hi ramarquezo, kcchan, yes that is indeed what we typically do here at UTS. Prep lots of libraries, QC them by generating a little bit of data on a nano flowcell, then balance them precisely for a subsequent full flowcell run. ramarquezo, feel free to swing by my office and introduce yourself sometime if you have more questions!
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...-
Channel: Articles
Today, 06:46 AM -
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Genome Sequencing Reveals Large, Repeat-Rich DNA in Trapdoor Spider Named for Stephen Colbert
by SEQadmin2
Started by SEQadmin2, 10-28-2026, 09:57 AM
|
0 responses
23 views
0 reactions
|
Last Post
by SEQadmin2
10-28-2026, 09:57 AM
|
||
|
Started by SEQadmin2, 10-28-2026, 09:51 AM
|
0 responses
15 views
0 reactions
|
Last Post
by SEQadmin2
10-28-2026, 09:51 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
68 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
48 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
Comment